Regulatory note — Products distributed in the United Kingdom are classified and supplied as Cannabis-Based Products for Medicinal Use (CBPMs) under Schedule 2 of the UK Misuse of Drugs Regulations 2001, released in line with MHRA guidance for unlicensed CBPMs. Products in other markets are supplied in compliance with the applicable regulatory requirements of each jurisdiction. This website is intended for medical professionals, licensed distributors, and qualified procurement teams. Not for patient self-referral or recreational use. Version 1.0 · April 2026 · Review annually. Produced by CNPG / Phant.